549
On 13 April 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 367. The active ingredient is Parathyroid hormone (1-34) transglutaminase fusion protein fibrin matrix complex for treatment of solitary bone cysts.